NR vs NAD+: How the Two Supplements Differ
Guide7 min readUpdated

The short answer
NR and NAD+ supplements differ in what the body gets. NR is a building block the body turns into NAD+, the helper molecule cells use to turn food into energy. NAD+ supplements supply the finished molecule. No cited trial compared them head to head, so neither is shown to work differently.
On this page9 sections
- 01What is NAD+, and what does it do in the body?
- 02What is NR, and how does the body use it?
- 03How do NR and NAD+ supplements differ?
- 04What have human trials found about NR?
- 05What does animal and laboratory research add?
- 06Where do these building blocks show up in food?
- 07What studies show
- 08What is not known yet
- 09Key takeaways
NR is a raw material and NAD+ is the finished helper molecule, and the human research cited here sits on the raw material side.
What is NAD+, and what does it do in the body?
NAD+ is a helper molecule found inside every cell. Think of it as a shuttle. It picks up small pieces from the fuel in food and drops them off where cells make energy. It also takes part in the work of enzymes that repair DNA. That is why scientists call it a central part of normal cell housekeeping.
The body does not store this molecule the way it stores fat or sugar. Cells build it, use it, break it down and build it again. The turnover never stops. Because of that constant rebuilding, researchers pay close attention to the raw materials that feed into it.
Levels are not fixed either. They shift with what a person eats, how old they are, and how hard their cells are working. Scientists have spent years looking for ways to support those levels. A 2024 review of ways to raise NAD+ drew mostly on research in model organisms, which are simple living things used in laboratories, and it describes several routes researchers have tried.
What is NR, and how does the body use it?
NR is one of the raw materials the body can turn into NAD+. It is a small molecule related to the B vitamin family. Cells take it in, add a few parts to it in a short series of steps, and the end product is NAD+.
A 2008 review of lab research grouped three vitamin forms together as raw materials for NAD+: nicotinic acid, nicotinamide, and NR. That review looked at how each form behaves at the molecular level. The three are not identical. They enter the chain at different points and the body handles each one in its own way.
This matters for anyone comparing supplement labels. Two products can both be described as support for NAD+ while containing different raw materials. The names on the panel tell the reader which starting point is in the package.
How do NR and NAD+ supplements differ?
The main difference is position in the chain. A supplement with NR supplies a starting piece. A supplement with NAD+ supplies the finished molecule itself. The body still decides what happens next in both cases.
There is also a difference in size. NAD+ is a larger molecule built from two linked parts. NR is one smaller piece. Size is one of the things chemists look at when they study how a molecule moves through the body. The papers cited on this page did not settle what happens to the whole finished molecule after a person swallows it.
The third difference is the research record. Most of the human work cited here used NR rather than the finished molecule. A 2026 review reported that NR and NMN taken by mouth raise blood NAD+, while any clinical benefit stays uncertain and depends on context. NMN is another building block the body can turn into NAD+.
So the honest short answer is this. The two forms are not the same molecule, and the evidence behind them is not the same size. Neither of those facts makes one a winner. They simply sit at different points in the same process.
What have human trials found about NR?
Two small trials in people stand behind the picture on this page. Both measured what happened to NAD+ in blood.
An open-label study in 8 healthy adults found that blood NAD+ rose in step with NR levels over 9 days [Small human study]. Open-label means everyone knew what the participants were taking. That design is useful for early questions and weak for firm conclusions.
A 6-week randomized crossover trial in healthy middle-aged and older adults found that NR was well tolerated and raised blood NAD+ [Small human study]. In a crossover design, each person spends time on each option. That lets researchers compare a person with their own earlier results.
Both trials were small. Small trials can show that something is worth studying further. They cannot show what would happen across a large and varied group of people. Reading them as a first look, rather than a final word, is the fair approach.
What does animal and laboratory research add?
Animal and cell research came first, and it still makes up a large part of this field. It shapes the questions human trials later ask.
A 2018 review of animal research looked at NAD+ boosting molecules given to old or unwell animals. Work like that helps scientists map out what a molecule does inside a living body. It does not tell a reader what to expect in a person. Animals and people differ in how they handle the same compound.
A 2023 review of NMN and NR covered their chemistry, their possible effects, and what research still needs to show. The last part of that list matters as much as the first. Open questions are part of the record, not a gap to paper over.
The 2024 review mentioned earlier makes a similar point about its own source material, since it drew mostly on research in model organisms. Readers who see bold claims online can check which kind of study sits behind them.
Where do these building blocks show up in food?
They show up in ordinary food. The 2023 review describes NMN and NR as NAD+ building blocks found in food, alongside their chemistry and possible effects. That is one reason researchers call them nutrition compounds rather than something foreign to the body.
The 2008 review of lab research made the same framing clear by describing these forms as vitamins in human nutrition. People take in raw materials for NAD+ every day without thinking about it. Supplements are a separate and more concentrated source, and the panel on the package is where those details live.
What studies show
Here is what each cited paper found, stated on its own.
- An open-label study in 8 healthy adults found that blood NAD+ rose in step with NR levels over 9 days [Small human study].
- A 6-week randomized crossover trial in healthy middle-aged and older adults found that NR was well tolerated and raised blood NAD+ [Small human study].
- A 2008 review of lab research compared three vitamin forms the body turns into NAD+ at the molecular level.
- A 2023 review covered NMN and NR, two NAD+ building blocks found in food, including their chemistry, possible effects, and what research still needs to show.
- A 2026 review reported that NR and NMN taken by mouth raise blood NAD+, while clinical benefit is uncertain and depends on context.
- A 2024 review went through ways to raise NAD+, drawing mostly on research in model organisms.
- A 2018 review of animal studies examined NAD+ boosting molecules in old or unwell animals.
What is not known yet
The gaps are easy to list once the findings are clear.
- No paper cited on this page compared swallowing the finished molecule against swallowing a building block, so the question of how they differ in people stays open.
- The open-label study in 8 healthy adults ran for 9 days, which leaves longer stretches of time unmeasured [Small human study].
- The 6-week crossover trial involved a small group of healthy middle-aged and older adults, so its findings cannot be stretched to everyone [Small human study].
- The 2026 review stated plainly that clinical benefit is uncertain and depends on context.
- The 2024 review rested mostly on research in model organisms, which leaves human questions unanswered.
- Findings in old or unwell animals from the 2018 review describe animals, not people.
- The 2023 review itself pointed to work that research still needs to do.
A blood measurement is also not the same as a result a person can feel. Rising blood NAD+ answers a chemistry question. What that means for daily life is a separate question, and the cited papers did not close it.
Key takeaways
- NR is a raw material the body turns into NAD+, while NAD+ is the finished helper molecule cells use during normal energy production.
- A 2008 review of lab research grouped nicotinic acid, nicotinamide, and NR as vitamin forms the body turns into NAD+.
- An open-label study in 8 healthy adults found blood NAD+ rose in step with NR levels over 9 days [Small human study].
- A 6-week crossover trial in healthy middle-aged and older adults found NR was well tolerated and raised blood NAD+ [Small human study].
- A 2026 review reported that oral NR and NMN raise blood NAD+ while clinical benefit remains uncertain.
- Much of the wider evidence, including a 2018 review of animal studies, comes from animals and model organisms rather than people.
Anyone weighing these two forms can bring the question to a healthcare provider, who can look at the whole picture for that person. For any question about use, follow the label directions. Reverra products are for healthy adults. Talk to your healthcare provider before starting any supplement, especially if you take medication, manage a condition, or are pregnant or nursing. These statements have not been evaluated by the Food and Drug Administration. Reverra products are dietary supplements and are not intended to diagnose, treat, cure, or prevent any disease.
Common questions
Is NR the same thing as NAD+?
No. NR is a raw material, and NAD+ is the finished helper molecule cells use during normal energy production. The body adds parts to the raw material in a short series of steps. A 2008 review of lab research described several vitamin forms the body turns into NAD+.
Does the body make NAD+ on its own?
Yes. Cells build this helper molecule, use it, break it down and build it again without stopping. Food supplies the raw materials for that work. A 2023 review described NMN and NR as NAD+ building blocks found in food, along with their chemistry and open questions.
What did human trials of NR measure?
They measured NAD+ in blood. An open-label study in 8 healthy adults found blood NAD+ rose in step with NR levels over 9 days [Small human study]. Both cited trials were small, so their findings are an early look rather than a settled answer.
Was NR well tolerated in research?
A 6-week randomized crossover trial in healthy middle-aged and older adults found that NR was well tolerated and raised blood NAD+ [Small human study]. That result comes from one small group over six weeks. Anyone with questions about tolerance should speak with a healthcare provider.
Do these supplements have a proven health benefit?
Not according to the papers cited here. A 2026 review reported that NR and NMN taken by mouth raise blood NAD+, while any clinical benefit stays uncertain and depends on context. A change in a blood measurement is a chemistry finding, not a health outcome.
What is NMN, and how does it relate to this comparison?
NMN is another building block the body can turn into NAD+. A 2023 review covered NMN and NR together, including their chemistry, possible effects, and what research still needs to show. It sits at a different point in the same chain inside cells.
Why is so much of this research done in animals?
Animal and laboratory work usually comes first and shapes later human questions. A 2018 review of animal studies examined NAD+ boosting molecules in old or unwell animals. Those results describe animals. People and animals can handle the same compound in different ways.
Does swallowing NAD+ itself work the same way as swallowing NR?
The papers cited on this page did not answer that. None of them compared the finished molecule against a building block in the same trial. NAD+ is a larger molecule built from two linked parts, while NR is one smaller piece. The question remains open in this evidence.
How should someone use a supplement with either form?
Follow the label directions. An article cannot set a serving for an individual, and this page does not give one. Anyone who takes medication, manages a condition, or has questions about starting a supplement should talk with their healthcare provider first, since the full picture matters for each person.
Does more NAD+ in blood mean more inside cells?
The cited trials measured blood, not the inside of every tissue. An open-label study in 8 healthy adults tracked blood NAD+ over 9 days [Small human study]. What happens across tissues over longer stretches of time was not measured in that work.
What does the 2024 review on raising NAD+ cover?
It walks through several ways researchers have tried to raise NAD+, drawing mostly on research in model organisms, which are simple living things used in laboratories. That source material is useful for mapping the field and limited for drawing conclusions about people.
Who should talk to a healthcare provider before starting one of these?
Reverra products are for healthy adults. Talk to your healthcare provider before starting any supplement, especially if you take medication, manage a condition, or are pregnant or nursing. A provider can review a person's full situation, which an article cannot do from a distance.
References
- 01An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers, 2017 PMID 29211728
- 02Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition, 2008 PMID 18429699
- 03NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health, 2023 PMID 37273100
- 04NAD+ biology and supplementation: From mechanisms to clinical perspectives, 2026 PMID 42489969
- 05NAD(+) Boosting Strategies, 2024 PMID 39693020
- 06Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence, 2018 PMID 29514064
- 07Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD(+) in healthy middle-aged and older adults, 2018 PMID 29599478
This article is for general information and is not medical advice. These statements have not been evaluated by the Food and Drug Administration. Reverra products are not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement.





